Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 10,000 shares at $75.17 ($752K) on 2017-08-22, disclosed to the SEC on 2017-08-23.
Open-market sale of $752k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $14.1M | — | Filing → |